CD47 and neoplasm: We observed a significant increase in the number of CD69− and CD69+CD103−/+ populations within both polyclonal CD8+ and SIINFEKL+ TIL (Figure 2i and j), suggesting that CD47 × PD‐L1 BisAb treatment promotes a wide‐spread influx of T cells including both tumor‐reactive and polyclonal T cell populations.